We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Wynn Resorts (WYNN) Gears Up for Q2 Earnings: A Beat in Store?
Read MoreHide Full Article
Wynn Resorts, Limited (WYNN - Free Report) is scheduled to report second-quarter 2019 results on Aug 6, after the closing bell.
In the last reported quarter, the company delivered a positive earnings surprise of 1.3%. However, the bottom line missed the Zacks Consensus Estimate in the three of the trailing four quarters, the average miss being 12.6%.
Which Way are Estimates Headed?
The Zacks Consensus Estimate for second-quarter earnings stands at $1.42, indicating a 7.2% decline from year-ago quarter’s reported figure. Notably, the consensus mark has witnessed downward revisions of 2.1% over the past 30 days. For quarterly revenues, the Zacks Consensus Estimate is pegged at $1,600 million, implying approximately 0.8% decline from the prior-year quarter’s reported number.
Factors at Play
Wynn Resorts top line in the second quarter is likely to be impacted by a marginal decline in Wynn Macau revenues. However, Las Vegas operations and Wynn Palace are likely to report impressive numbers. The Zacks Consensus Estimate for second-quarter revenues from Las Vegas operations is pinned at $451 million, up 2% year over year. Moreover, revenues from Wynn Palace are expected to come in at $692 million, up 11.4% year over year.
Apart from the gaming business in Macau, the company has been increasingly focusing on driving non-gaming revenues. Given the decent visitation pattern in Macau, infrastructure development and government’s efforts to boost tourism in Macau, non-gaming sources are expected to boost Wynn Resorts’ revenues in the to-be-reported quarter.
In order to boost performance in Las Vegas, the company has remodeled rooms at its properties and the baccarat pit. The number of visits has been increasing every year. With the improving job scenario and stabilizing gas prices, the consumer spending environment in domestic markets is also improving. Backed by the optimism surrounding tourism in Las Vegas and increasing visitation pattern, revenues are likely to grow in the second quarter.
According to the Zacks model, a company with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) has a good chance of beating estimates if it also has a positive Earnings ESP. Zacks Rank #4 (Sell) or 5 (Strong Sell) stocks are best avoided, especially if they have a negative Earnings ESP. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Here are some stocks from the Consumer Discretionary sector that investors may consider as our model shows that these too have the right combination of elements to come up with an earnings beat in the to-be-reported quarter:
SeaWorld has an Earnings ESP of +11.01% and a Zacks Rank #2. The company is scheduled to report quarterly numbers on Aug 6.
Callaway Golf has an Earnings ESP of +2.97% and a Zacks Rank #1. The company is scheduled to report quarterly numbers on Aug 8.
Playa Hotels & Resorts N.V. (PLYA - Free Report) has a Zacks Rank #3 and an Earnings ESP of +50.00%. The company is scheduled to report quarterly numbers on Aug 7.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Wynn Resorts (WYNN) Gears Up for Q2 Earnings: A Beat in Store?
Wynn Resorts, Limited (WYNN - Free Report) is scheduled to report second-quarter 2019 results on Aug 6, after the closing bell.
In the last reported quarter, the company delivered a positive earnings surprise of 1.3%. However, the bottom line missed the Zacks Consensus Estimate in the three of the trailing four quarters, the average miss being 12.6%.
Which Way are Estimates Headed?
The Zacks Consensus Estimate for second-quarter earnings stands at $1.42, indicating a 7.2% decline from year-ago quarter’s reported figure. Notably, the consensus mark has witnessed downward revisions of 2.1% over the past 30 days. For quarterly revenues, the Zacks Consensus Estimate is pegged at $1,600 million, implying approximately 0.8% decline from the prior-year quarter’s reported number.
Factors at Play
Wynn Resorts top line in the second quarter is likely to be impacted by a marginal decline in Wynn Macau revenues. However, Las Vegas operations and Wynn Palace are likely to report impressive numbers. The Zacks Consensus Estimate for second-quarter revenues from Las Vegas operations is pinned at $451 million, up 2% year over year. Moreover, revenues from Wynn Palace are expected to come in at $692 million, up 11.4% year over year.
Apart from the gaming business in Macau, the company has been increasingly focusing on driving non-gaming revenues. Given the decent visitation pattern in Macau, infrastructure development and government’s efforts to boost tourism in Macau, non-gaming sources are expected to boost Wynn Resorts’ revenues in the to-be-reported quarter.
In order to boost performance in Las Vegas, the company has remodeled rooms at its properties and the baccarat pit. The number of visits has been increasing every year. With the improving job scenario and stabilizing gas prices, the consumer spending environment in domestic markets is also improving. Backed by the optimism surrounding tourism in Las Vegas and increasing visitation pattern, revenues are likely to grow in the second quarter.
Wynn Resorts, Limited Price and EPS Surprise
Wynn Resorts, Limited price-eps-surprise | Wynn Resorts, Limited Quote
Our Model Suggests a Beat
According to the Zacks model, a company with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) has a good chance of beating estimates if it also has a positive Earnings ESP. Zacks Rank #4 (Sell) or 5 (Strong Sell) stocks are best avoided, especially if they have a negative Earnings ESP. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Wynn Resorts has an Earnings ESP of +2.65% and a Zacks Rank #3, a combination that suggests that the company is likely to beat estimates. You can see the complete list of today’s Zacks #1 Rank stocks here.
Stocks Poised to Beat Earnings Estimates
Here are some stocks from the Consumer Discretionary sector that investors may consider as our model shows that these too have the right combination of elements to come up with an earnings beat in the to-be-reported quarter:
SeaWorld has an Earnings ESP of +11.01% and a Zacks Rank #2. The company is scheduled to report quarterly numbers on Aug 6.
Callaway Golf has an Earnings ESP of +2.97% and a Zacks Rank #1. The company is scheduled to report quarterly numbers on Aug 8.
Playa Hotels & Resorts N.V. (PLYA - Free Report) has a Zacks Rank #3 and an Earnings ESP of +50.00%. The company is scheduled to report quarterly numbers on Aug 7.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>